These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22356740)

  • 1. Preoperative concurrent chemoradiotherapy for stages II-IV oral squamous cell carcinoma: a retrospective analysis and the future possibility of this treatment strategy.
    Kirita T; Yamanaka Y; Imai Y; Yamakawa N; Aoki K; Nakagawa Y; Yagyuu T; Hasegawa M
    Int J Oral Maxillofac Surg; 2012 Apr; 41(4):421-8. PubMed ID: 22356740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor.
    Klug C; Wutzl A; Kermer C; Ploder O; Sulzbacher I; Selzer E; Voracek M; Oeckher M; Ewers R; Millesi W
    Int J Oral Maxillofac Surg; 2005 May; 34(3):262-7. PubMed ID: 15741034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological assessment of tumour regression, nodal stage and status of resection margins determines prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.
    Wedemeyer I; Kreppel M; Scheer M; Zöller JE; Büttner R; Drebber U
    Oral Dis; 2014 Apr; 20(3):e81-9. PubMed ID: 23746299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary tumour resection of tongue carcinoma based on response to preoperative therapy.
    Kirita T; Ohgi K; Kawakami M; Miyawaki S; Okamoto M; Yamanaka Y; Sugimura M
    Int J Oral Maxillofac Surg; 2002 Jun; 31(3):267-72. PubMed ID: 12190132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of response to preoperative chemoradiotherapy and residual tumor grades in tongue carcinoma.
    Kirita T; Shimooka H; Yamanaka Y; Tatebayashi S; Yamamoto K; Nishimine M; Sugimura M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):293-300. PubMed ID: 11250626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
    Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
    Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients.
    Freier K; Engel M; Lindel K; Flechtenmacher C; Mühling J; Hassfeld S; Hofele C
    Oral Oncol; 2008 Feb; 44(2):116-23. PubMed ID: 17350327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study.
    Kessler P; Grabenbauer G; Leher A; Bloch-Birkholz A; Vairaktaris E; Neukam FW
    Br J Oral Maxillofac Surg; 2008 Jan; 46(1):1-5. PubMed ID: 17931758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of oral cancer occult metastasis and survival of T1-T2N0 oral cancer patients.
    El-Naaj IA; Leiser Y; Shveis M; Sabo E; Peled M
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2674-9. PubMed ID: 21571415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
    Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
    Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Five year survival of patients with primary oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study].
    Kessler P; Grabenbauer G; Leher A; Bloch-Birkholz A; Vairaktaris E; Neukam FW; Sauer R
    Strahlenther Onkol; 2007 Apr; 183(4):184-9. PubMed ID: 17406799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
    González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.
    Sher DJ; Thotakura V; Balboni TA; Norris CM; Haddad RI; Posner MR; Lorch J; Goguen LA; Annino DJ; Tishler RB
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e215-22. PubMed ID: 21531515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose preoperative chemoradiation therapy compared with surgery alone with or without postoperative radiotherapy in patients with head and neck carcinoma.
    Mücke T; Konen M; Wagenpfeil S; Kesting MR; Wolff KD; Hölzle F
    Ann Surg Oncol; 2011 Oct; 18(10):2739-47. PubMed ID: 21424882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue].
    Yang AK; Liu TR; Chen FJ; Ma XF; Guo ZM; Song M; Li QL; Zeng ZY
    Ai Zheng; 2008 Dec; 27(12):1315-20. PubMed ID: 19080001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
    Kurita H; Koike T; Miyazawa H; Uehara S; Kobayashi H; Kurashina K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):915-21. PubMed ID: 16835480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage treatment for recurrent oral squamous cell carcinoma.
    Sun GW; Tang EY; Yang XD; Hu QG
    J Craniofac Surg; 2009 Jul; 20(4):1093-6. PubMed ID: 19521259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neck recurrence after level I-IV or I-III selective neck dissection in the management of the clinically N0 neck in patients with oral squamous cell carcinoma.
    Bajwa MS; McMillan R; Khattak O; Thomas M; Krishnan OP; Webster K
    Head Neck; 2011 Mar; 33(3):403-6. PubMed ID: 20629073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.